LSIPR 50 2017: Kyle Bass

10-11-2017

Kyle Bass was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

kyle-bass-jpg.JPG

Name: Kyle Bass  

Organisation: Hayman Capital Management 


LSIPR 2017, Kyle Bass, Hayman Capital Management, investment, Coalition for Affordable Drugs, IPR, life-saving drugs, PTAB

LSIPR